Spotlight on the Bolar Exemption: What Will Proposed Changes to the Scope of the Exemption Mean for Life Science Patent Practitioners in Europe?
Takanori Abe
Managing Partner
Abe & Partners
Rais Amils Arnal
Partner
Pérez-Llorca
Markus Grammel
Partner
Grünecker
- An overview of how the Bolar Exemption has been interpreted and applied across different jurisdictions in Europe
- Understanding how to navigate the particularities of the Bolar provisions in key jurisdictions
- Analyzing the proposed changes to the bolar exemption in the new EU Pharma Package
- How does the new law broaden the scope of the exemption and what will the implications be for patent practitioners?